{"id":70545,"date":"2012-02-28T14:00:55","date_gmt":"2012-02-28T14:00:55","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/leading-german-researcher-awarded-elseviers-2011-tetrahedron-prize.php"},"modified":"2024-08-17T17:56:21","modified_gmt":"2024-08-17T21:56:21","slug":"leading-german-researcher-awarded-elseviers-2011-tetrahedron-prize","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/chemistry\/leading-german-researcher-awarded-elseviers-2011-tetrahedron-prize.php","title":{"rendered":"Leading German Researcher Awarded Elsevier&#39;s 2011 Tetrahedron Prize"},"content":{"rendered":"<p><p>    AMSTERDAM, February 28, 2012 \/PRNewswire\/ --  <\/p>\n<p class=\"c1\">    Professor Dr. Manfred T. Reetz honored for his work on    synthetic organic chemistry  <\/p>\n<p>        Elsevier, a world-leading provider of scientific, technical    and medical information products and services, announces that    leading German scientist, Professor Dr. Manfred T. Reetz    (Emeritus) of the Max-Planck-Institut fur Kohlenforschung and    Hans Meerwein Research Professor at Philipps-Universit\u00e4t,    Marburg, has been awarded the 2011 Tetrahedron Prize for    Creativity in Organic Chemistry.  <\/p>\n<p>    The Executive Board of Editors of Elsevier's Tetrahedron    Publications selected Professor Reetz for his many outstanding    contributions to synthetic organic chemistry, especially for    his work on enantioselective catalysis to control    stereoselectivity. He has been prominent in the discovery and    development of enzyme catalysts for asymmetric reactions. These    enzyme catalysts can be developed in the laboratory to suit a    specific reaction using a process of directed evolution:    repeatedly selecting and growing the host organism which shows    the highest yield of the enzyme required.  <\/p>\n<p>    \"Winners of the Tetrahedron prize are leaders in their field.    They are the scientists who, through their outstanding    creativity in organic chemistry, have moved the field in a new    and significant direction. Elsevier is proud to recognize this    creativity by the presentation of this prize,\" Diddel    Francissen, Executive Publisher for the Tetrahedron    Publications at Elsevier, said of the annual prize.  <\/p>\n<p>    Elsevier's Tetrahedron Prize consists of a gold medal and a    monetary award. Established in 1980 to honor the memory of the    founding co-Chairmen of the Tetrahedron Publications, Professor    Sir Robert Robinson and Professor Robert Burns Woodward, it is    awarded for creativity in Organic Chemistry or Bioorganic and    Medicinal Chemistry. Previous recipients include: Albert    Eschenmoser, Elias J. Corey, Gilbert Stork, Arthur J. Birch,    Michael J.S. Dewar, William S. Johnson, Ryoji Noyori; &nbsp;K.    Barry Sharpless, Alan R. Battersby; &nbsp;A. Ian Scott, Samuel    Danishefsky, Stuart L. Schreiber, David A. Evans, Teruaki    Mukaiyama, Henri B. Kagan, Peter B. Dervan, Yoshito Kishi,    Kyriacos C. Nicolaou, Robert H. Grubbs, Dieter Seebach, Koji    Nakanishi, Bernd Giese, Hisashi Yamamoto, J. Fraser Stoddart,    Larry E. Overman, Steven V. Ley and Satoshi ?mura.  <\/p>\n<p>    The Tetrahedron Prize will be presented to Professor Reetz at    the     Fall 2012 American Chemical Society National Meeting in    Philadelphia, USA.  <\/p>\n<p>    For more information on the Tetrahedron Prize please     click here.  <\/p>\n<p class=\"c2\">    About Tetrahedron Publications&nbsp;  <\/p>\n<p>    Elsevier's Tetrahedron cluster of journals consists of:    Tetrahedron, Tetrahedron Letters, Tetrahedron Assymetry,    Bioorganic and Medicinal Chemistry and Bioorganic and Medicinal    Chemistry Letters. All these journals provide an international    forum for the publication of research in all areas of    (bio)organic and medicinal chemistry.  <\/p>\n<p class=\"c2\">    About Elsevier  <\/p>\n<p>    Elsevier is a world-leading provider of scientific, technical    and medical information products and services. The company    works in partnership with the global science and health    communities to publish more than 2,000 journals, including    The Lancet and Cell, and close to 20,000 book titles, including    major reference works from Mosby and Saunders. Elsevier's    online solutions include     SciVerse ScienceDirect,     SciVerse Scopus,     Reaxys,     MD Consult and     Nursing Consult, which enhance the productivity of science    and health professionals, and the     SciVal suite and     MEDai's Pinpoint Review, which help research and health    care institutions deliver better outcomes more    cost-effectively.  <\/p>\n<p>    A global business headquartered in Amsterdam,     Elsevier employs 7,000 people worldwide. The company is    part of     Reed Elsevier Group PLC, a world-leading publisher and    information provider, which is jointly owned by Reed Elsevier    PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext    Amsterdam), REL (London Stock Exchange), RUK and ENL (New York    Stock Exchange).  <\/p>\n<p>    Media contact<br \/>    Diddel Francissen<br \/>    Elsevier<br \/>    +31-20-4852588<br \/>        <a href=\"mailto:d.francissen@elsevier.com\">d.francissen@elsevier.com<\/a>  <\/p>\n<p><\/p>\n<p>See the original post here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/leading-german-researcher-awarded-elseviers-110600176.html\" title=\"Leading German Researcher Awarded Elsevier&#39;s 2011 Tetrahedron Prize\" rel=\"noopener\">Leading German Researcher Awarded Elsevier&#39;s 2011 Tetrahedron Prize<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> AMSTERDAM, February 28, 2012 \/PRNewswire\/ -- Professor Dr. Manfred T. Reetz honored for his work on synthetic organic chemistry Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces that leading German scientist, Professor Dr <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/chemistry\/leading-german-researcher-awarded-elseviers-2011-tetrahedron-prize.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246863],"tags":[],"class_list":["post-70545","post","type-post","status-publish","format-standard","hentry","category-chemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/70545"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=70545"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/70545\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=70545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=70545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=70545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}